MUSC Opioid Initiatives:
An Update
Kelly Barth, DO Associate Professor, Departments of Psychiatry & Internal Medicine
MUSC Opioid Initiatives: An Update Kelly Barth, DO Associate - - PowerPoint PPT Presentation
MUSC Opioid Initiatives: An Update Kelly Barth, DO Associate Professor, Departments of Psychiatry & Internal Medicine Naloxone World- EMR Data for distribution & renowned screening, evaluation on addiction prescribing inpatient
Kelly Barth, DO Associate Professor, Departments of Psychiatry & Internal Medicine
EMR Data for screening, prescribing feedback &
measurements Naloxone distribution & evaluation on inpatient administrations World- renowned addiction researchers
Wakeman & Barnett, NEJM, 2018
Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015). National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment. A merican Journal of Public Health, 105(8), e55-63. doi:10.2105/AJPH.2015.302664
25 million patients 2 million patients
› 25 million with chronic pain › 23 million with severe pain
› medical treatment › lost productivity
9
› improved disability & catastrophizing
› improved pain and function › effects lasting up to 6 months
› incorporates both of the above › effective for pain & disability
$20 co-pay/week Multiple co-pay + facility fee $20 co-pay/week
month
› Improved pain and function (sustained over 1 year) › Less health care utilization › Significant decrease in medical costs (60-90%) › Higher rate of return to work
Kamper, et al, BMJ 2015
create a hybrid of telehealth + in-person care
innovative programs
addictions as the opioid crisis continues to evolve